Clinical Trial Update: Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Qutenza®-Remodulin® in pulmonary arterial hypertension and pain conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• QUTENZA (Capsaicin)
• Remodulin (treprostinil)

Snippet

Sponsor: Imperial College London | Conditions: Pulmonary Hypertension, Pain | Phase 2 | Status: COMPLETED